ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Alternatives
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Dividend
    • Dual Impact
    • Emerging Markets
    • Energy Infrastructure
    • ESG
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Future ETFs
    • Global Diversification
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Megatrends
    • Modern Alpha
    • Multi-Asset
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Thematic Investing
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
    • ETF Data for Journalists
    • ETF Nerds
  • Research
    • First Bitcoin ETF
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF Trends on Videos
    • ETF Trends on Podcasts
    • ETF Prime Podcast
  • Company
    • About Us
    • Swag Store
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Modern Alpha Channel – ETF Database
  2. Biden’s “Cancer Moonshot” Brings Biotech Focus to U.S.
Modern Alpha Channel - ETF Database
Share

Biden’s "Cancer Moonshot" Brings Biotech Focus to U.S.

Karrie GordonSep 15, 2022
2022-09-15

President Biden spoke at the Kennedy Presidential Library on the 60th anniversary of JFK’s moonshot speech on Monday, September 12, outlining his plans for building out American research to end cancer, which he describes as his own personal presidential moonshot, reported NPR. The president announced in February his cancer moonshot goal to reduce cancer deaths by half in the next quarter century as well as improve the supports within the system for those fighting cancer or who have survived it.

Biden acknowledged the inequities in diagnosing and treating cancer within the U.S., with vast differences in outcomes based on an individual’s race, sexual orientation, gender identity, disability, and where they live. He hopes to elevate the entire system in a push to cure cancer by supporting research, biotechnology, biomedicine, and more in the U.S., and laid out the framework for government support in the sector.

“We know too little about why treatments work for some patients, but a different patient with the same disease, it doesn’t work for. We still lack strategies in developing treatments for some cancers,” Biden said, reiterating that “we don’t do enough to help patients and families navigate the cancer care system.”

The White House appointed Dr. Renee Wegrzyn as head of the new Advanced Research Projects Agency for Health (ARPA-H), prior to the president’s speech. ARPA-H is an agency created by the president in February with the purpose of amplifying the government’s support of biomedical and health research.

Biden announced during his speech the launch of a National Biotechnology and Biomanufacturing Initiative via an executive order. The initiative is designed to bring biotech and biomanufacturing back to the U.S. and ensure that any cancer breakthroughs that happen are done domestically. Currently much of the biotech research and manufacturing happens overseas in countries such as China.

“ARPA-H will have the singular purpose to drive breakthroughs to prevent, detect and treat diseases, including cancer, Alzheimer’s, diabetes and other diseases and enable us to live healthier lives,” Biden said.

Bringing research, labs, and manufacturing back to the U.S. will drastically reduce supply chain interruptions as well as drive job creation domestically.

Capturing Domestic Biotech Growth With WDNA

Biden’s initiatives will drive strong growth across the biotechnology field within the U.S., and the WisdomTree BioRevolution Fund (WDNA ) is poised to capture. The fund seeks to track the WisdomTree BioRevolution Index and offers exposure to companies that will benefit by the growth and evolution in biotechnologies and genetics.

Companies contained within the fund focus on a variety of areas within biotech: applying genetic technologies to treat and prevent disease; applying human genetic technology to new products that are personalized to individuals; transforming agriculture, aquaculture, and food production; biological re-engineering that’s used for biomanufacturing; and DNA storage.

The index is a modified equally weighted index that rebalances and is reconstituted semi-annually.

The fund already has a strong focus within the U.S. at 79.49% weight, with smaller allocations in other countries such as the U.K., Germany, Denmark, Japan, and more.

WDNA has an expense ratio of 0.45%.

For more news, information, and strategy, visit the Modern Alpha Channel.


Content continues below advertisement

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X